Evidence map›Paper›PMID 37687207›Full record

ArticleMolecules (Basel, Switzerland)2023

In Silico Modeling and Structural Analysis of Soluble Epoxide Hydrolase Inhibitors for Enhanced Therapeutic Design.

Shuvam Sar, Soumya Mitra, Parthasarathi Panda, Subhash C Mandal, Nilanjan Ghosh, Amit Kumar Halder, Maria Natalia D S Cordeiro

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shuvam SarDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.ORCID 0009-0004-2321-9467
Soumya MitraDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.ORCID 0000-0002-0664-0389
Parthasarathi PandaDr. B. C. Roy College of Pharmacy and Allied Health Sciences, Campus Dr. Meghnad Saha Sarani, Durgapur 713206, India.ORCID 0000-0003-0071-708X
Subhash C MandalDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.ORCID 0000-0002-9079-489X
Nilanjan GhoshDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.ORCID 0000-0003-0520-0952
Amit Kumar HalderDr. B. C. Roy College of Pharmacy and Allied Health Sciences, Campus Dr. Meghnad Saha Sarani, Durgapur 713206, India.ORCID 0000-0002-4818-9047
Maria Natalia D S CordeiroLAQV@REQUIMTE-Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.ORCID 0000-0003-3375-8670
Jadavpur University · INUniversidade do Porto · PT

Funding

Fundação para a Ciência e Tecnologia UIDB/50006/2020
6 · The paper itself

Abstract

Human soluble epoxide hydrolase (sEH), a dual-functioning homodimeric enzyme with hydrolase and phosphatase activities, is known for its pivotal role in the hydrolysis of epoxyeicosatrienoic acids. Inhibitors targeting sEH have shown promising potential in the treatment of various life-threatening diseases. In this study, we employed a range of in silico modeling approaches to investigate a diverse dataset of structurally distinct sEH inhibitors. Our primary aim was to develop predictive and validated models while gaining insights into the structural requirements necessary for achieving higher inhibitory potential. To accomplish this, we initially calculated molecular descriptors using nine different descriptor-calculating tools, coupled with stochastic and non-stochastic feature selection strategies, to identify the most statistically significant linear 2D-QSAR model. The resulting model highlighted the critical roles played by topological characteristics, 2D pharmacophore features, and specific physicochemical properties in enhancing inhibitory potential. In addition to conventional 2D-QSAR modeling, we implemented the Transformer-CNN methodology to develop QSAR models, enabling us to obtain structural interpretations based on the Layer-wise Relevance Propagation (LRP) algorithm. Moreover, a comprehensive 3D-QSAR analysis provided additional insights into the structural requirements of these compounds as potent sEH inhibitors. To validate the findings from the QSAR modeling studies, we performed molecular dynamics (MD) simulations using selected compounds from the dataset. The simulation results offered crucial insights into receptor-ligand interactions, supporting the predictions obtained from the QSAR models. Collectively, our work serves as an essential guideline for the rational design of novel sEH inhibitors with enhanced therapeutic potential. Importantly, all the in silico studies were performed using open-access tools to ensure reproducibility and accessibility.

Indexed as

Epoxide HydrolasesMolecular Dynamics SimulationElectric Power SuppliesHumansHydrolasesReproducibility of ResultsEpoxide HydrolasesHydrolasesfeature selectionmolecular dynamicspharmacophoreQSARsoluble epoxide hydrolaseTransformer-CNN

Identifiers

PMID37687207
PMCPMC10490281
OpenAlexW4386324995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.